SCHEMBL1675210

SCHEMBL1675210

CC(C)(C)CNc1ncnc2ccc(-c3ccc(C(=O)O)o3)cc12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 14/20 0.70
CLK1 P49759 6/20 0.70
CLK2 P49760 6/20 0.70
DYRK1B Q9Y463 6/20 0.70
DYRK1A Q13627 6/20 0.65
CLK3 P49761 1/20 0.55
USP2 O75604 5/20 0.45
CYP1A2 P05177 5/20 0.45
ALDH1A1 P00352 5/20 0.45
HSD17B10 Q99714 5/20 0.45
CYP3A4 P08684 5/20 0.45
LMNA P02545 5/20 0.45
CYP2D6 P10635 4/20 0.45
CYP2C19 P33261 4/20 0.45
MAPK1 P28482 3/20 0.45
PIK3CA P42336 1/20 0.43
TSHR P16473 4/20 0.43
PDE5A O76074 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CYP2C9 P11712 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675232 0.88 CLK4 (0.66) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675235 0.84 CLK4 (0.75) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675131 0.82 CLK4 (1.00) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675052 0.80 CLK4 (1.00) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675107 0.79 CLK4 (0.70) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675152 0.79 CLK4 (0.75) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1674989 0.78 CLK4 (0.62) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675093 0.77 CLK4 (0.61) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL6763978 0.73 ERBB2 (0.66) CLK4CLK1CLK2DYRK1B
Hydrochloric Acid SCHEMBL6766485 0.73 ERBB2 (0.65) CLK4CLK1CLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed